Literature DB >> 21669535

4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.

Zhu-Ping Xiao1, Hui Ouyang, Xu-Dong Wang, Peng-Cheng Lv, Ze-Jun Huang, She-Rong Yu, Tian-Fang Yi, Ye-Ling Yang, Hai-Liang Zhu.   

Abstract

A series of novel 4-alkoxy-3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors were synthesized. Of these compounds, 3-(4-hydroxyphenyl)-4-(2-morpholinoethoxy)furan-2(5H)-one (27) was the most potent. The binding model and structure-activity relationship indicate that replacement of morpholine-ring in the side chain of 27 with a substituent containing more hydrophilic groups would be more suitable for further modification. Antibacterial assay revealed that the synthetic compounds are effective against growth of Gram-positive organisms, and 27 is the most potent agent against Staphylococcus aureus ATCC 25923 with MIC(50) value of 0.23 μg/mL.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669535     DOI: 10.1016/j.bmc.2011.05.042

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  3-(4-Bromo-phen-yl)-4-[2-(4-nitro-phen-yl)hydrazin-yl]furan-2(5H)-one.

Authors:  Zhu-Ping Xiao; Li-Cheng Yi; Jia-Liang Li; Bo Zhang; Mei-Ling Liao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-29

2.  3-(4-Bromo-phen-yl)-4-(4-hy-droxy-anilino)furan-2(5H)-one.

Authors:  Wanxi Peng; Lansheng Wang; Fengjuan Wu; Qiu Xu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-11

3.  New molecular insights into the tyrosyl-tRNA synthase inhibitors: CoMFA, CoMSIA analyses and molecular docking studies.

Authors:  Shengrong Li; Jilin Fan; Chengkang Peng; Yiqun Chang; Lianxia Guo; Jinsong Hou; Miaoqi Huang; Biyuan Wu; Junxia Zheng; Longxin Lin; Gaokeng Xiao; Weimin Chen; Guochao Liao; Jialiang Guo; Pinghua Sun
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.